Table 1. Characteristics of Study Participants at Baseline.

	Treatment Groups
	DEC/ALB x 1	DEC/ALB x 2	IVM/DEC/ALB x 1
N	61	61	60
Age Median (range)	34 (18-62)	37 (18-61)	40 (19-60)
Sex (M/F)	34/27	30/31	28/32
Hemoglobin gm/dL (mean ± SD)	11.2 (1.8)	11.2 (1.7)	11.4 (1.8)
Weight kg (mean ± SD)	51 (5)	52 (7)	50 (6)
Microfilaria/mL geomean (Range)	744 (52-8,290)	596 (61-9,656)	699 (55-15,621)
Circulating Filarial Antigen ng/mL geomean (Range)	79 (18-340)	81 (15-325)	72 (17-348)

DEC – diethylcarbamazine, ALB – albendazole, IVM – ivermectin